Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
State of the Art Patient Evaluation and Treatment of Nail Unit Squamous Cell Carcinoma
Description
The presentation discusses the state-of-the-art evaluation and treatment of nail unit squamous cell carcinoma (SCC), emphasizing the challenges and advancements in managing this rare condition. It distinguishes between surgical and non-surgical treatments, with surgical approaches being the standard of care. The literature reviewed highlights a lack of large patient series, typically involving limited case studies from tertiary care centers. This tumor is associated with high-risk HPV, leading to discussions on patient counseling and potential bone involvement in over 20% of cases. Surgical options like amputation are deemed effective but come with significant morbidity, urging clinicians to consider less invasive options like Mohs surgery or wide local excision which provide lower recurrence rates. The speaker underscores the importance of achieving clear surgical margins, particularly in complicated cases that may involve bone. Techniques used in Mohs surgery, such as excising tumors with the nail plate intact and addressing bone involvement directly, are highlighted as critical to optimize outcomes. The presentation concludes that understanding HPV association, tumor proximity to bone, and employing Mohs or wide local excision are key to effective treatment strategies for nail unit SCC.
View moreConclusions
- Mohs surgery and wide local excision (WLE) are preferred treatments for nail squamous cell carcinoma (SCC) due to lower recurrence rates compared to amputation.
- Nail SCC is associated with high-risk HPV and can act as a sexually transmitted infection.
- Bone involvement is frequent in nail SCC and must be addressed in surgical planning.
- Non-surgical treatments exist but lack robust evidence for efficacy compared to surgical options.
- Complete surgical excision with margin confirmation improves patient outcomes in nail SCC treatment.
- Digital amputation is indicated only when there is confirmed bone invasion and not as a first-line treatment.
- Future studies are needed to establish standardized treatment protocols and evaluate the efficacy of emerging therapies for nail SCC.
- Lombardi et al, 1990 (n = 1)
- Ashby, 1956 (n = 2)
- Guitart et al, 1990 (n = 12)
- Wessendorf et al, 2009 (n = 1)
- Sbai et al, 2009 (n = 1)
- Gelmann, 1963 (n = 1)
- Eliezri et al, 1990 (n = 2)
- DePond et al, 2009 (n = 1)
- Turowski et al. 2009 (n = 2)
- Shapiro and Baraf, 1970 (n = 7)
- Ruiz Santiago and Morales-Burgos, 2011 (n = 1)
- Echt et al. 1991 (n = 1)
- Choughri et al, 2011 (n = 1)
- de Berker et al, 1996 (n = 7)
- Dika et al, 2012 (n = 11)
- Zabawski et al, 2001 (n = 5)
- Hale and Dawber, 1998 (n = 2)
- Batalla et al, 2014 (n = 4)
- Chang et al, 1999 (n = 1)
- Tomsick and Menn, 1981 (n = 8)
- Alam et al, 2003 (n = 2)
- Dobson et al. 2002 (n = 1)
- Peterson et al, 2004 (n = 3)
- Ormerod and de Berker, 2015 (n = 17)
- Wong et al, 2004 (n = 3)
- Nicholls et al, 2015 (n = 1)
- Shelley and Shelley, 1986 (n = 1)
- Feily, 2015 (n = 1)
- Goldberg and Robins, 1986 (n = 1)
- Schwartz, 1988 (n = 1)
- Kurokawa et al, 2006 (n = 1)
- Shimizu A, et al. J Am Acad Dermatol 2019;81:1358-70
- Starace M, et al. Dermatol Pract Concept. 2018;8(3):238-244.
- Stiff KM, Jellinek N, Knackstedt TJ. Plast Reconstr Surg. 2022 Feb 14. Epub ahead of print. PMID: 35157617.
- Clark M, et al. Dermatol Surg 2020;46:1375-1381
- Carlioz V, et al. Clin Exp Dermatol. 2021 Jan;46(1):82-88
- Lee TM, et al .. Int J Dermatol. 2019 Apr;58(4):428-432
- Dika E ., et al. Dermatol Surg 2019;45:365-370
- Boespflug A, et al .. J Am Acad Dermatol. 2018
- Prasad A, et al. J Cutan Pathol. 2022 Jul;49(7):675-677
- Jeon YJ, et al. Br J Dermatol. 2020 Jul;183(1):e1
- Ammar A, et al. Skeletal Radiology 2023;52:613-622
- Barone H, et al. J Cutan Med Surg 2023;27(1) 51-59
- Topin-Ruiz S, et al. JAMA Dermatol. 2017 May 1;153(5):442-448
- Dermatol Surg 2022;48(3):267-273